SOURCE: The Bedford Report

The Bedford Report

August 19, 2010 12:39 ET

Analyst Research on J&J, Fiserv, Sanofi-Aventis and Becton Dickenson -- Buffett Raises His Stake

Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report

TORONTO--(Marketwire - August 19, 2010) -  The Bedford Report is pleased to announce that its latest Market Update analyzing recent news and events on Johnson & Johnson (NYSE: JNJ), Fiserv, Inc. (NASDAQ: FISV), Sanofi-Aventis (NYSE: SNY) and Becton Dickenson & Co. (NYSE: BDX) has been released. Sign up today at to access our complimentary analyst reports.

Recently Warren Buffett and Berkshire Hathaway bet big on healthcare. They raised their stake in Johnson & Johnson by close to 73% in what's considered a classic Buffett "value play." Berkshire also added to its stake in the medical device maker Becton Dickenson and drugmaker Sanofi-Aventis. To learn more about Warren Buffett's reasoning behind these big healthcare bets, we encourage you to sign up at

Buffett also strayed from traditions and picked up 4.4 million shares of the mid-cap tech company, Fiserv. Buffett has repeatedly stated that technology is not within his "circle of competence", so why this tech play? Find out at

Our updated analyst reports on J&J, Fiserv, Becton Dickenson and Sanofi-Aventis include:
-- An unbiased view and rating of the company
-- Recent key developments
-- Solid analyst summary -- who's saying what and why?
-- In-depth industry analysis and outlook
-- Major upcoming events to watch out for

Take the few minutes to register with us at and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action. has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer:

Contact Information